Newton, MA, United States of America

Noa Cohen

This inventor holds 1 USPTO granted patent. Top assignee: Northeastern University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noa Cohen. Retrieved from https://idiyas.com/inventor/noa-cohen-poy2e5mm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Noa Cohen in Microfluidic Technology

Introduction

Noa Cohen is an innovative inventor based in Newton, MA (US). He has made significant contributions to the field of microfluidics, particularly in the analysis of tumor cell microenvironments. His work focuses on creating devices that can mimic the complexities of tumor biology, which is crucial for advancing cancer research and treatment.

Latest Patents

Noa Cohen holds a patent for a microfluidic device and method for the analysis of tumor cell microenvironments. This device enables high throughput generation and analysis of defined three-dimensional cell spheroids with controlled geometry, size, and cell composition. The cell spheroids created by this invention closely mimic tumor microenvironments, including pathophysiological gradients, cell composition, and the heterogeneity of the tumor mass. This innovation provides a more realistic model for testing drug responses, particularly in understanding resistance to drug penetration.

Career Highlights

Noa Cohen is affiliated with Northeastern University, where he continues to push the boundaries of research in microfluidic technology. His work is instrumental in developing tools that enhance the understanding of cancer biology and improve therapeutic strategies.

Collaborations

Noa collaborates with talented individuals such as Pooja Sabhachandani and Tania Konry, who contribute to the research and development of innovative solutions in the field.

Conclusion

Noa Cohen's contributions to microfluidic technology represent a significant advancement in cancer research. His patented device offers a promising approach to studying tumor microenvironments and testing antitumor agents. This work is vital for the future of cancer treatment and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…